146 related articles for article (PubMed ID: 35696242)
21. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
Li H; Jin X; Zhang Z; Xing Y; Kong X
Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
[TBL] [Abstract][Full Text] [Related]
22. Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.
Gao X; Liu Y; Deeb D; Arbab AS; Gautam SC
J Exp Ther Oncol; 2014; 10(4):275-83. PubMed ID: 25509983
[TBL] [Abstract][Full Text] [Related]
23. The (+)-Brevipolide H Displays Anticancer Activity against Human Castration-Resistant Prostate Cancer: The Role of Oxidative Stress and Akt/mTOR/p70S6K-Dependent Pathways in G1 Checkpoint Arrest and Apoptosis.
Sheng YH; Leu WJ; Chen CN; Hsu JL; Liu YT; Hsu LC; Hou DR; Guh JH
Molecules; 2020 Jun; 25(12):. PubMed ID: 32630532
[TBL] [Abstract][Full Text] [Related]
24. β-Elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/ mTOR signalling pathways.
Zhan YH; Liu J; Qu XJ; Hou KZ; Wang KF; Liu YP; Wu B
Asian Pac J Cancer Prev; 2012; 13(6):2739-44. PubMed ID: 22938451
[TBL] [Abstract][Full Text] [Related]
25. Selenoprotein S regulates tumorigenesis of clear cell renal cell carcinoma through AKT/ GSK3β/NF-κB signaling pathway.
Mao H; Zhao Y; Lei L; Hu Y; Zhu H; Wang R; Ni D; Liu J; Xu L; Xia H; Zhang Z; Ma M; Pan Z; Zhou Q; Xie Y
Gene; 2022 Jul; 832():146559. PubMed ID: 35569765
[TBL] [Abstract][Full Text] [Related]
26. Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling.
Gao X; Liu Y; Deeb D; Arbab AS; Guo AM; Dulchavsky SA; Gautam SC
Anticancer Res; 2011 Nov; 31(11):3673-81. PubMed ID: 22110186
[TBL] [Abstract][Full Text] [Related]
27. BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling.
Urban BC; Collard TJ; Eagle CJ; Southern SL; Greenhough A; Hamdollah-Zadeh M; Ghosh A; Poulsom R; Paraskeva C; Silver A; Williams AC
Gut; 2016 Jul; 65(7):1151-64. PubMed ID: 26033966
[TBL] [Abstract][Full Text] [Related]
28. Estrogen upregulates inflammatory signals through NF-κB, IFN-γ, and nitric oxide via Akt/mTOR pathway in the lymph node lymphocytes of middle-aged female rats.
Pratap UP; Sharma HR; Mohanty A; Kale P; Gopinath S; Hima L; Priyanka HP; ThyagaRajan S
Int Immunopharmacol; 2015 Dec; 29(2):591-598. PubMed ID: 26440402
[TBL] [Abstract][Full Text] [Related]
29. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922
[TBL] [Abstract][Full Text] [Related]
30. Rotundarpene inhibits TNF-α-induced activation of the Akt, mTOR, and NF-κB pathways, and the JNK and p38 associated with production of reactive oxygen species.
Kim A; Nam YJ; Shin YK; Lee MS; Sohn DS; Lee CS
Mol Cell Biochem; 2017 Oct; 434(1-2):113-125. PubMed ID: 28432555
[TBL] [Abstract][Full Text] [Related]
31. Synergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/Akt/mTOR and NF-κB signal pathways in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Biomed Pharmacother; 2016 Oct; 83():22-32. PubMed ID: 27470546
[TBL] [Abstract][Full Text] [Related]
32. Mycotoxin verrucarin A inhibits proliferation and induces apoptosis in prostate cancer cells by inhibiting prosurvival Akt/NF-kB/mTOR signaling.
Liu Y; Gao X; Deeb D; Zhang Y; Shaw J; Valeriote FA; Gautam SC
J Exp Ther Oncol; 2016 Nov; 11(4):251-260. PubMed ID: 27849335
[TBL] [Abstract][Full Text] [Related]
33. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation.
Park KR; Nam D; Yun HM; Lee SG; Jang HJ; Sethi G; Cho SK; Ahn KS
Cancer Lett; 2011 Dec; 312(2):178-88. PubMed ID: 21924548
[TBL] [Abstract][Full Text] [Related]
34. IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.
Sommermann TG; O'Neill K; Plas DR; Cahir-McFarland E
Cancer Res; 2011 Dec; 71(23):7291-300. PubMed ID: 21987722
[TBL] [Abstract][Full Text] [Related]
35. Delphinidin prevents hypoxia-induced mouse embryonic stem cell apoptosis through reduction of intracellular reactive oxygen species-mediated activation of JNK and NF-κB, and Akt inhibition.
Seo BN; Ryu JM; Yun SP; Jeon JH; Park SS; Oh KB; Park JK; Han HJ
Apoptosis; 2013 Jul; 18(7):811-24. PubMed ID: 23584725
[TBL] [Abstract][Full Text] [Related]
36. Eicosapentaenoic acid induced SKOV-3 cell apoptosis through ERK1/2-mTOR-NF-κB pathways.
Han L; Zhang Y; Meng M; Cheng D; Wang C
Anticancer Drugs; 2016 Aug; 27(7):635-42. PubMed ID: 27176035
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.
Minhajuddin M; Bijli KM; Fazal F; Sassano A; Nakayama KI; Hay N; Platanias LC; Rahman A
J Biol Chem; 2009 Feb; 284(7):4052-61. PubMed ID: 19074768
[TBL] [Abstract][Full Text] [Related]
38. IOX-101 Reverses Drug Resistance Through Suppression of Akt/mTOR/NF-κB Signaling in Cancer Stem Cell-Like, Sphere-Forming NSCLC Cell.
Fayi MA; Alamri A; Rajagopalan P
Oncol Res; 2020 Mar; 28(2):177-189. PubMed ID: 31771696
[TBL] [Abstract][Full Text] [Related]
39. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
[TBL] [Abstract][Full Text] [Related]
40. PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men.
Ribback S; Cigliano A; Kroeger N; Pilo MG; Terracciano L; Burchardt M; Bannasch P; Calvisi DF; Dombrowski F
Oncotarget; 2015 May; 6(15):13036-48. PubMed ID: 25948777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
